This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Nov;48(5):487-8.

doi: 10.1016/j.ejvs.2014.07.007. Epub 2014 Aug 21.

New oral anticoagulants in the management of venous thromboembolism: a major advance?

S Sciascia¹, B J Hunt²

Affiliations

Affiliations

¹ Guy's & St Thomas' Hospital, London, UK; Centro di Ricerche di Immunologia Clinica ed Immunopatologia e Documentazione su Malattie Rare (CMID), Università di Torino, Turin, Italy.
² Guy's & St Thomas' Hospital, London, UK; King's College, London, UK. Electronic address: beverley.hunt@gstt.nhs.uk.

PMID: 25150440
DOI: 10.1016/j.ejvs.2014.07.007

Free article

Editorial

New oral anticoagulants in the management of venous thromboembolism: a major advance?

S Sciascia et al. Eur J Vasc Endovasc Surg. 2014 Nov.

Free article

. 2014 Nov;48(5):487-8.

doi: 10.1016/j.ejvs.2014.07.007. Epub 2014 Aug 21.

Authors

S Sciascia¹, B J Hunt²

Affiliations

¹ Guy's & St Thomas' Hospital, London, UK; Centro di Ricerche di Immunologia Clinica ed Immunopatologia e Documentazione su Malattie Rare (CMID), Università di Torino, Turin, Italy.
² Guy's & St Thomas' Hospital, London, UK; King's College, London, UK. Electronic address: beverley.hunt@gstt.nhs.uk.

PMID: 25150440
DOI: 10.1016/j.ejvs.2014.07.007

No abstract available

PubMed Disclaimer

Comment on

Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Kakkos SK, et al. Eur J Vasc Endovasc Surg. 2014 Nov;48(5):565-75. doi: 10.1016/j.ejvs.2014.05.001. Epub 2014 Jun 18. Eur J Vasc Endovasc Surg. 2014. PMID: 24951377

Similar articles

Re: 'Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.
Spanos K, Giannoukas AD. Spanos K, et al. Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353. doi: 10.1016/j.ejvs.2014.11.019. Epub 2014 Dec 30. Eur J Vasc Endovasc Surg. 2015. PMID: 25556084 No abstract available.
Response to 'Re: Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Kakkos SK, et al. Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353-4. doi: 10.1016/j.ejvs.2014.12.007. Epub 2014 Dec 30. Eur J Vasc Endovasc Surg. 2015. PMID: 25556083 No abstract available.
Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons.
Hurst KV, Lee R, Milosevic I, Handa A. Hurst KV, et al. Eur J Vasc Endovasc Surg. 2015 Jul;50(1):126-7. doi: 10.1016/j.ejvs.2015.02.022. Epub 2015 Apr 29. Eur J Vasc Endovasc Surg. 2015. PMID: 25933476 No abstract available.
New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G, Becattini C, Franco L. Agnelli G, et al. Best Pract Res Clin Haematol. 2013 Jun;26(2):151-61. doi: 10.1016/j.beha.2013.07.005. Epub 2013 Jul 22. Best Pract Res Clin Haematol. 2013. PMID: 23953903 Review.
Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Kakkos SK, et al. Eur J Vasc Endovasc Surg. 2014 Nov;48(5):565-75. doi: 10.1016/j.ejvs.2014.05.001. Epub 2014 Jun 18. Eur J Vasc Endovasc Surg. 2014. PMID: 24951377

See all similar articles

Cited by

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome.
Arora S, Nair S, Prabhu R, Avanthika C, Jhaveri S, Samayam S, Katta MR, Agarwal P. Arora S, et al. Cureus. 2021 Oct 24;13(10):e19009. doi: 10.7759/cureus.19009. eCollection 2021 Oct. Cureus. 2021. PMID: 34824926 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information